Sign in
VRXAW Stock Price, Chart, Stats & News
Veraxa Biotech AG
Save
Veraxa Biotech AG (VRXAW) does not currently pay a dividend.
3.06M
Market cap
–
Current P/E
–
Forward P/E
VRXAW chart
1M
3M
1Y
5Y
Loading chart...
About
Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]
Similar securities
Based on sector and market capitalization
Report issue